ICI Rechallenge for Advanced NSCLC With Long-Term Response to First-Line ICI

Abroad (travel likely)RecruitingPHASE2

Conditions

Non-small Cell Lung Cancer

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Peking Union Medical College Hospital, Beijing, China
Contact: Study coordinator (Minjiang Chen, MD.) · minjiangchen@163.com · +8618618340880

Study leads

Minjiang Chen, MD.
Principal Investigator
Peking Union Medical College Hospital

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Study to Assess the Efficacy and Safety of Rina-S in Participants With Non-small Cell Lung Cancer

Non-small Cell Lung Cancer (NSCLC)

Abroad (travel likely)RecruitingPHASE2

Fountain Valley, United States · Santa Rosa, United States

A Phase Ib/II Study of an Anti-HER3 Antibody, HMBD-001, With Cetuximab +/- Docetaxel in Advanced Squamous Cell Cancers

Advanced or Metastatic Squamous Non-Small Cell Lung Cancer · Advanced Head and Neck Squamous Cell Carcinoma · Advanced Esophageal Squamous Cell Carcinoma

Abroad (travel likely)RecruitingPHASE1, PHASE2

Sydney, Australia · Westmead, Australia

A Study of Ivonescimab, Chemotherapy, and Stereotactic Radiosurgery for People With Non-Small Cell Lung Cancer

Non-Small Cell Lung Cancer

Abroad (travel likely)RecruitingPHASE1, PHASE2

Basking Ridge, United States · Middletown, United States

A Study of BIO 300 and Thoracic Radiation Therapy in People With Non-Small Cell Lung Cancer and Interstitial Lung Disease

NSCLC · NSCLC, Stage I · NSCLC Stage II

Abroad (travel likely)RecruitingPHASE2

Basking Ridge, United States · Middletown, United States